Knoll Mavik and Tarka
Executive Summary
Kos Pharmaceuticals will co-promote the antihypertensives Mavik (trandolapril) and Tarka (trandolapril/verapamil) beginning in the third quarter. Miami-based Kos plans to promote the drugs with the 200-person sales force it uses to promote its cholesterol-lowering product Niaspan